Halozyme to Participate in the TD Cowen 45th Annual Healthcare Conference
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, will present and host investor meetings at the TD Cowen 45th Annual Healthcare Conference.
TD Cowen analyst Andrew Sherman raised the firm’s price target on Axon (AXON) to $725 from $700 and keeps a Buy rating on the shares. The firm ...
AllianceBernstein (NYSE:AB) was downgraded at TD Cowen after Equitable Holdings (NYSE:EQH) announced a tender offer for up to ...
Textron (NYSE:TXT – Get Free Report) was upgraded by investment analysts at TD Cowen to a “hold” rating in a report released ...
TD Cowen analyst William Katz maintained a Buy rating on Apollo Global Management (APO – Research Report) today and set a price target of ...
TD Cowen was established in 1918 as a bond trading firm and quickly expanded into clearing and execution services. By the 1970s, it had carved a niche in railroad bonds and grown a solid research ...
Domino’s Pizza (NASDAQ:DPZ – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at TD Cowen in a ...
Microsoft Corp. has canceled some leases for US data center capacity, according to TD Cowen, raising broader concerns over ...
In a report released today, Andrew Kligerman from TD Cowen maintained a Hold rating on Skyward Specialty Insurance Group, Inc. (SKWD – Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback